First he pioneered a new way of making life. Now he wants to try it in people
By Karen Weintraub,
STAT
| 07. 08. 2016
PORTLAND, Ore. — The next great advance in fertility treatments may rest with five young monkeys in a lab outside of town.
...
If so, the three-parent fertilization technique will likely be tried in humans, potentially helping women with certain genetic glitches give birth to healthy children. The same approach might also someday provide older women a chance to extend their fertility by freshening up their eggs with contributions from another woman.
...
“If someone were to proceed with it now, my own view is that’s probably irresponsible. There are so many question marks. I just think it’s premature,” said Paul Knoepfler, a stem cell biologist at the University of California, Davis.
Continue reading on STAT
Image via Flickr/Amy
Related Articles
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
By Karen Weintraub, Endpoints News | 09.16.2026
To better understand certain neuropsychiatric disorders, researchers at Stanford University have bred rodents that lack a cortex and hippocampus and then replaced those missing brain cells with human ones.
The altered mice, a scientific first, provided insights that would not...
By Ryan Cross, Endpoints News | 09.02.2026
The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new fuel to a yearslong debate about the danger of the gene therapy field’s most-used delivery...
